Agilon Health Raises FY2026 Sales Guidance from $5.410B-$5.580B to $5.680B-$5.805B vs $5.452B Est

Benzinga Newsdesk www.benzinga.com Positive 93.6%

Neg 0% Neu 0% Pos 93.6%

Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.410 billion-$5.580 billion to $5.680 billion-$5.805 billion vs $5.452 billion estimate.